Menactra Alternatives Compared
| Menactra (meningococcal conjugate vaccine) | Ceftriaxone | Ciprofloxacin |
|
|---|
| Menactra (meningococcal conjugate vaccine) | Ceftriaxone | Ciprofloxacin |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Meningococcal Disease Prophylaxis. Menactra may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Bacterial Infection, Bone infection, Bacterial Endocarditis Prevention, Bacteremia, Bronchitis, Chancroid, Conjunctivitis, Endocarditis, Endometritis, Epididymitis - Non-Specific... View more |
Prescription only
Ciprofloxacin is an effective antibiotic that treats a wide variety of infections; however, it should not be given to children aged less than 18. In adults, it should be reserved for infections that... View more |
||||||||||||||||||||||||
| More about Menactra (meningococcal conjugate vaccine) | More about Ceftriaxone | More about Ciprofloxacin | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Menactra has an average rating of 1.0 out of 10 from a total of 2 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Ceftriaxone has an average rating of 8.5 out of 10 from a total of 175 ratings on Drugs.com. 82% of reviewers reported a positive effect, while 9% reported a negative effect. |
Ciprofloxacin has an average rating of 5.0 out of 10 from a total of 935 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 46% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Menactra side effects |
View all Ceftriaxone side effects |
View all Ciprofloxacin side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Menactra prices |
View all Ceftriaxone prices |
View all Ciprofloxacin prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other meningococcal conjugate vaccine brands include: MenQuadfi, Menveo |
N/A |
Cipro, Cipro Cystitis Pack, Cipro I.V., Cipro XR | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
8 hours |
4 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 298 drugs are known to interact with Menactra:
|
A total of 58 drugs are known to interact with Ceftriaxone:
|
A total of 713 drugs are known to interact with Ciprofloxacin:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
December 21, 1984 |
October 22, 1987 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.